HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells

Anticancer Research

Volumn 28, Issue 4 B, 2008, Pages 2121-2127

  Inamura, Kentaro ^a   Togashi, Yuki ^a   Ninomiya, Hironori ^a   Shimoji, Takashi ^a   Noda, Tetsuo ^a   Ishikawa, Yuichi ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

Gene expression analysis; HOXB2; Invasion assay; Lung cancer; Microarray

Indexed keywords

BETA4 INTEGRIN; BINDING PROTEIN; GLYCOPROTEIN; LAMININ; LAMININ ALPHA4; LAMININ ALPHA5; MAC 2 BINDING PROTEIN; MATRIGEL; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; HOX GENE; HOXB2 GENE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; UPREGULATION;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 49049120711     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Brundage MD, Davies D and Mackillop WJ: Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122: 1037-1057, 2002.
2. Miyoshi T, Satoh Y, Okumura S et al: Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 27: 101-109, 2003.
3. Inamura K, Togashi Y, Nomura K et al: Up-regulation of PTEN at the transcriptional level is an adverse prognostic factor in female lung adenocarcinomas. Lung Cancer 57: 201-206, 2007.
4. Inamura K, Shimoji T, Ninomiya H et al: A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity. Hum Pathol 38: 702-709, 2007.
5. Gehring WJ and Hiromi Y: Homeotic genes and the homeobox. Annu Rev Genet 20: 147-173, 1986.
6. Dennis G Jr, Sherman BT, Hosack DA et al: DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4: P3, 2003.
7. Timpl R and Brown JC: The laminins. Matrix Biol 14: 275-281, 1994.
8. Ljubimova JY, Lakhter AJ, Loksh A et al: Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res 61: 5601-5610, 2001.
9. Vainionpaa N, Lehto VP, Tryggvason K et al: Alpha4 chain laminins are widely expressed in renal cell carcinomas and have a de-adhesive function. Lab Invest 87: 780-791, 2007.
10. Pouliot N, Saunders NA and Kaur P: Laminin 10/11: an alternative adhesive ligand for epidermal keratinocytes with a functional role in promoting proliferation and migration. Exp Dermatol 11: 387-397, 2002.
11. Marchetti A, Tinari N, Buttitta F et al: Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res 62: 2535-2539, 2002.
12. Mercurio AM and Rabinovitz I: Towards a mechanistic understanding of tumor invasion - lessons from the alpha 6 beta 4 integrin. Semin Cancer Biol 11: 129-141, 2001
13. Chauhan SS, Goldstein LJ and Gottesman MM: Expression of cathepsin L in human tumors. Cancer Res 51: 1478-1481, 1991.
14. Rapa I, Volante M, Cappia S et al: Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth. Am J Clin Pathol 125: 847-854, 2006.
15. Puppin C, Puglisi F, Pellizzari L et al: HEX expression and localization in normal mammary gland and breast carcinoma. BMC Cancer 6: 192, 2006.
16. Hellerbrand C, Muhlbauer M, Wallner S et al: Promoter- hypermethylation is causing functional relevant down-regulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Carcinogenesis 27: 64-72, 2006.
17. Golpon HA, Geraci MW, Moore MD et al: HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol 158: 955-966, 2001.
18. Hatano M, Roberts CW, Minden M et al: Deregulation of a homeobox gene, HOX11, by the t(10;14) in T-cell leukemia. Science 253: 79-82, 1991.
19. Cillo C, Barba P, Freschi G et al: HOX gene expression in normal and neoplastic human kidney. Int J Cancer 51: 892-897, 1992.
20. De Vita G, Barba P, Odartchenko N et al: Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 29A: 887-893, 1993.
21. Naora H, Yang YQ, Montz FJ et al: A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci USA 98: 4060-4065, 2001.
22. Cantile M, Pettinato G, Procino A et al: In vivo expression of the whole HOX gene network in human breast cancer. Eur J Cancer 39:257-264, 2003.
23. Miyazaki YJ, Hamada J, Tada M et al: HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and - independent pathways in A549 cells. Oncogene 21: 798-808, 2002.
24. Segara D, Biankin AV, Kench JG et al: Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res 11: 3587-3596, 2005.
25. Singhal S, Vachani A, Antin-Ozerkis D et al: Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 11: 3974-3986, 2005.
26. Potti A, Mukherjee S, Petersen R et al: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 355: 570-580, 2006.
27. Sun Z and Yang P: Refining prognosis in non-small-cell lung cancer. N Engl J Med 356: 190; author reply 190-191, 2007.
28. Sun Z, Aubry MC, Deschamps C et al: Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases. J Thorac Cardiovasc Surg 131: 1014-1020, 2006.